Performance Status During Treatment With Pemetrexed in Patients With NSCLC
NCT00540241
·
clinicaltrials.gov ↗
COMPLETED
Status
542
Enrollment
INDUSTRY
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
Pemetrexed
Sponsor
Eli Lilly and Company